ArticleClinical immunology (Orlando, Fla.)2023

A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia.

Jin Y Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.